Mike Martin

Mike Martin serves as President and CEO at ISPE. ISPE operates in the pharmaceuticals sector with approximately 540.0 employees. The company is headquartered in North Salem, Indiana.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 3 executives at ISPE.
• • 832 executive contacts are available in Indiana.
• • Our database includes 201,469 c suite-level executives.

Salesforce Outlook Hubspot Zendesk StackAdapt Active Campaign Ad Unit 320 x 50 Google Maps Zencoder Facebook Login (Connect) LiveChat Linkedin Login WordPress.org Ad Unit 300 x 600 Microsoft-IIS Moat Facebook Widget DoubleClick Google Analytics Linkedin Widget Paypal Adobe Media Optimizer DoubleClick Conversion Mobile Friendly Typekit Google AdWords Conversion Bing Ads Google Dynamic Remarketing EventsAir by Centium Cedexis Radar Google Font API ASP.NET Ad Unit 728 x 90 Ad Unit 300 x 250 Google Tag Manager YouTube GoToWebinar Bootstrap Framework Eventbrite New Relic Hotjar Google AdSense Qualaroo AddThis Facebook Custom Audiences Clicky Linkedin Marketing Solutions Google Maps (Non Paid Users) Vimeo ShareThis reCAPTCHA JW Player

pharmaceutical education & training pharmaceutical guidance documents pharmaceutical professional community building networking career solutions drug shortages pharmaceutical quality metrics blend uniformity & content uniformity initiative pharmaceutical manufacturing pharmaceutical engineering quality assurance regulatory compliance conference training member networking pharma 4.0 single-use technologies quality management gamp guidelines facility management product development supply chain innovation biotechnology life sciences aseptic processing digital transformation training programs data integrity operational excellence process validation microbial control clinical supply systems engineering standards sustainability ai in pharma pharmaceutical quality knowledge management emerging technologies continuous improvement validation processes quality control research collaboration industry standards medicinal products pharmaceutical lifecycle process development engineering change management risk management change management pharma education webinars good practice guides sustainability initiatives emerging leaders women in pharma pharmaceutical innovation networking opportunities manufacturing innovation supply chain resilience regulatory insights workforce development technical resources training courses professional development community engagement collaboration quality medicines global presence technical professionals educational resources industry leadership biopharmaceuticals engineering professionals innovation solutions member benefits technical efficiency industry challenges knowledge sharing volunteer engagement pharmaceuticals medical environmental services renewables & environment

YA

Yara Almouti CEO and Projects Director at ISPE

MH

Mark Hernick Chief Operating Officer at ISPE

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

How can I contact Mike Martin?

Mike Martin's verified email address is available on MessageCEO. They currently work at ISPE. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Mike Martin lead?

Mike Martin is President and CEO at ISPE, a company in the pharmaceuticals sector with 540.0 employees. The company is based in North Salem, Indiana.

What industry is Mike Martin in?

Mike Martin works in the pharmaceuticals industry as President and CEO at ISPE. MessageCEO provides verified contact information for executives across all major industries.

Is Mike Martin's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mike Martin's profile is kept up-to-date with the latest available information.

Last updated: April 8, 2026